Our previous work emphasized the use of acetate-PET as a prognostic tool to predict survival in patients with PCa recurrence after prostatectomy, in which a highly favourable outcome was seen in subjects with no or minimal pathological 11C-acetate uptake even when PSA was well above 1 ng/mL18. This evidence concerns the gene KLK3 and posterior cortical atrophy.